The cost of gastric band surgery in the UK ranges from £1,450 to £8,000 at private clinics. The NHS may cover the surgery for patients who meet specific health criteria, such as a BMI over 40 or a BMI over 35 with obesity-related health conditions.

The gastric balloon is a temporary, non-surgical weight-loss option in which a balloon is placed in the stomach and inflated. It reduces stomach capacity, helping patients feel full on smaller meals. This procedure is ideal for those who need assistance with weight loss but are not ready for permanent bariatric surgery.

Another term for the Roux-en-Y gastric bypass, the Roux bypass is highly regarded for its effectiveness in helping patients lose weight and improve health conditions related to obesity. Named after the French surgeon César Roux, this procedure is a combination of both restrictive and malabsorptive techniques. It requires a lifetime commitment to dietary changes, exercise, and regular follow-up with healthcare professionals.

Abdominal surgery covers a wide range of procedures, from bariatric surgeries to hernia repairs and cancer resections. Recovery time and hospital stay depend on the type of surgery performed, with some requiring only a few days in the hospital, while others may need extended stays for observation and healing.

The cost of Roux-en-Y gastric bypass surgery varies based on location, healthcare provider, and whether the patient has insurance coverage. In the U.S., the cost ranges from $20,000 to $30,000, depending on the hospital and specific circumstances. In countries with public healthcare systems, such as the UK or Canada, the surgery may be covered, though waiting times could be long. Many insurance companies in the U.S. cover bariatric surgery if it’s deemed medically necessary, but patients must meet specific... +More

Similar to stomach stapling, gastric stapling is a weight-loss surgery where staples are used to partition the stomach. The procedure has largely been replaced by more advanced surgeries like the gastric sleeve and Roux-en-Y bypass, which offer better long-term results and fewer complications.

Gastritis is inflammation of the stomach lining, while Irritable Bowel Syndrome (IBS) affects the intestines and causes chronic discomfort without inflammation. While both conditions involve digestive issues, gastritis typically causes nausea and upper abdominal pain, whereas IBS presents with bloating, diarrhea, or constipation.

A GI malignancy refers to any cancerous growth within the gastrointestinal tract. These cancers are often aggressive and can spread quickly if not detected early. Colon cancer, stomach cancer, and pancreatic cancer are common forms of GI malignancy. Gastroenterologists play a vital role in screening for these cancers through procedures like colonoscopies and endoscopies.

The post-op sleeve diet is vital for healing and weight loss after sleeve gastrectomy. It begins with liquids, followed by pureed foods, and eventually includes solid foods. Protein intake is prioritized, and patients must avoid high-fat, high-sugar foods to prevent complications like nausea or dumping syndrome.

Patients typically need a Body Mass Index (BMI) of 35 or higher, with obesity-related health conditions, or a BMI of 40 or more to qualify for gastric sleeve surgery. This surgery, known as Vertical Sleeve Gastrectomy (VSG), involves removing about 80% of the stomach to reduce food intake and is one of the most popular bariatric procedures.

Irritable Bowel Syndrome (IBS) and gastritis are two distinct conditions, though both cause abdominal discomfort. IBS is a chronic condition affecting the large intestine, while gastritis involves inflammation of the stomach lining. Both can be triggered by stress, poor diet, or infections, and treatment usually involves dietary adjustments and medications to manage symptoms.

Wegovy (semaglutide) is a medication that helps with weight loss by mimicking a hormone that regulates appetite. It is prescribed to individuals with obesity or those with weight-related health problems. In the UK, Wegovy has been approved for NHS use for patients who meet certain criteria, providing a non-surgical option for those seeking medical weight-loss assistance.

In medical terms, GI stands for Gastrointestinal, referring to the digestive system, which includes the stomach, intestines, and other associated organs. GI disorders encompass a wide range of conditions that affect digestion, including gastritis, irritable bowel syndrome (IBS), and gastrointestinal cancers.

Semaglutide is a weight-loss medication that mimics a hormone regulating appetite and food intake. In the UK, it is marketed under the brand names Ozempic (for diabetes) and Wegovy (for obesity). It is prescribed to individuals struggling with weight management, often in conjunction with diet and exercise.

Gastro refers to gastrointestinal conditions broadly, while gastritis specifically refers to inflammation of the stomach lining. Gastro disorders can include a range of conditions affecting the entire digestive tract, whereas gastritis is a localized condition of the stomach.